Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:01:11 2024-05-17 pm EDT 5-day change 1st Jan Change
28.64 USD -0.97% Intraday chart for Pfizer, Inc. +2.25% -0.52%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 60.41B Sales 2025 * 62.71B Capitalization 162B
Net income 2024 * 7.78B Net income 2025 * 11.29B EV / Sales 2024 * 3.65 x
Net Debt 2024 * 58.11B Net Debt 2025 * 49.97B EV / Sales 2025 * 3.38 x
P/E ratio 2024 *
19.9 x
P/E ratio 2025 *
14 x
Employees 88,000
Yield 2024 *
5.83%
Yield 2025 *
5.94%
Free-Float 59.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.05%
1 week+2.25%
Current month+11.79%
1 month+12.67%
3 months+3.69%
6 months-4.28%
Current year-0.52%
More quotes
1 week
28.17
Extreme 28.17
29.03
1 month
25.20
Extreme 25.2
29.03
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-17 28.64 -0.97% 26,106,406
24-05-16 28.92 +0.35% 40,077,782
24-05-15 28.82 +1.55% 38,376,257
24-05-14 28.38 -0.21% 23,530,856
24-05-13 28.44 +1.54% 39,609,758

Delayed Quote Nyse, May 17, 2024 at 04:01 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.64 USD
Average target price
31.94 USD
Spread / Average Target
+11.52%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW